We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Renal Cell Carcinoma

Journal Scan / Research · August 26, 2020

First-Line Systemic Therapy for mRCC

Cancer Immunology, Immunotherapy: CII

 

Additional Info

Cancer Immunology, Immunotherapy: CII
Systemic Therapy for Metastatic Renal Cell Carcinoma in the First-Line Setting: A Systematic Review and Network Meta-Analysis
Cancer Immunol. Immunother. 2020 Aug 05;[EPub Ahead of Print], K Mori, H Mostafaei, N Miura, PI Karakiewicz, S Luzzago, M Schmidinger, A Bruchbacher, B Pradere, S Egawa, SF Shariat

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading